Large-scale SPPS capacity in Braine-l’Alleud starts production
See media releaseInnovation for large-scale peptide production
See our presentation at a recent broker event related to GLP-1
Download presentationCreating the future in peptides
We lead innovation in peptide API’s to the benefit of millions of patients
Contact usAhead on green peptide chemistry
Together we improve process performance while reducing the environmental footprint
Learn moreMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs
13 Jan 2025 - This collaboration offers an integrated solution for customers seeking to outsource the development and manufacturing of microbial and mammalian-expressed peptide drugs, with scalable options that address […]
Read moreDoubling of production capacity at the manufacturing site in Malmö
8 Jan 2025 - Baar, 8 January 2025 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide-based active pharmaceutical ingredients, announces the planned doubling of solid-phase peptide […]
Read more